Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651563.RA9WQElP4dXpKTTYy5H12xVKoB9xmcSe_3lLQ8qB7WUxE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651563.RA9WQElP4dXpKTTYy5H12xVKoB9xmcSe_3lLQ8qB7WUxE130_assertion type Assertion NP651563.RA9WQElP4dXpKTTYy5H12xVKoB9xmcSe_3lLQ8qB7WUxE130_head.
- NP651563.RA9WQElP4dXpKTTYy5H12xVKoB9xmcSe_3lLQ8qB7WUxE130_assertion description "[Four of the 10 genes with the greatest differences in expression between patients and controls, S100A8 and S100A7 (upregulated), and loricrin and filaggrin (downregulated), were epidermal differentiation genes located on 1q21, a locus previously reported to have a genetic linkage with AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651563.RA9WQElP4dXpKTTYy5H12xVKoB9xmcSe_3lLQ8qB7WUxE130_provenance.
- NP651563.RA9WQElP4dXpKTTYy5H12xVKoB9xmcSe_3lLQ8qB7WUxE130_assertion evidence source_evidence_literature NP651563.RA9WQElP4dXpKTTYy5H12xVKoB9xmcSe_3lLQ8qB7WUxE130_provenance.
- NP651563.RA9WQElP4dXpKTTYy5H12xVKoB9xmcSe_3lLQ8qB7WUxE130_assertion SIO_000772 15656815 NP651563.RA9WQElP4dXpKTTYy5H12xVKoB9xmcSe_3lLQ8qB7WUxE130_provenance.
- NP651563.RA9WQElP4dXpKTTYy5H12xVKoB9xmcSe_3lLQ8qB7WUxE130_assertion wasDerivedFrom befree-20140225 NP651563.RA9WQElP4dXpKTTYy5H12xVKoB9xmcSe_3lLQ8qB7WUxE130_provenance.
- NP651563.RA9WQElP4dXpKTTYy5H12xVKoB9xmcSe_3lLQ8qB7WUxE130_assertion wasGeneratedBy ECO_0000203 NP651563.RA9WQElP4dXpKTTYy5H12xVKoB9xmcSe_3lLQ8qB7WUxE130_provenance.